Skyviews Life Science

Day-to-day investment leadership falls to co-founders Dr. Stefan Catsicas and Dr. Irène Corthésy Malnoë. Catsicas, the managing partner, previously held the CTO role at Nestlé, while Corthésy Malnoë was the chief scientific officer of Nestlé Health Science. The firm describes itself as a privately held advisory company, indicating that both partners guide sourcing and diligence.

Sourcing relies heavily on the academic and corporate networks of its founders. Stefan Catsicas serves on the board of Singapore's A*STAR, giving the firm visibility into early-stage research emerging from that government agency's labs. The firm's membership in the Swiss Biotech Association provides additional proximity to European life-science startups.

It is structured as an advisory company, not a single-family office itself. Skyviews manages Precision Health Corporation, the investment vehicle for the Alkhawaja family office (AMK Investment Office), making it an outsourced investment function rather than a blind-pool fund manager. This setup allows the founders to apply their scientific expertise without raising third-party capital.

Publicly available information describes Skyviews as identifying investment opportunities in private and public companies directly, with no mention of participating as a limited partner in external funds. Its advisory relationship with Precision Health Corporation points primarily toward direct company investments.

The firm concentrates on early-stage opportunities, spanning seed and startup phases. Its strategy page frames its focus around companies developing "better drugs, advanced technology platforms, preventive strategies, personalized solutions and more natural foods," hallmarks of capital-intensive early-stage life-science ventures.